Authority: Supreme Court of India

Order Date: 27-07-2026

Case Overview

  • Parties: Appellant – Ras Al Khaimah Investment Authority; Respondent – Matrix Pharmacorps Private Limited & Anr.
  • Civil Appeal Nos. 12993‑12994/2025; also linked with CA Nos. 12561‑12566/2025 (XVII‑B) and SLP(C) Nos. 27277‑27279/2025 (XII‑A) and 35892/2025 (XII‑A).
  • Numerous Interlocutory Applications (IA) filed, including IA No. 314889/2025, 254551/2025, 294780/2025, 254549/2025, 254550/2025, 254544/2025, 314907/2025, 294787/2025, 256723/2025, 256720/2025, 256722/2025, 11895/2026, 297354/2025, 294590/2025, 240366/2025, 240364/2025, 321803/2025, 8901/2026, 321801/2025, 321804/2025, covering orders, directions, clarifications, exemptions, permissions, and stay applications.
  • Hearing conducted on 27‑07‑2026 before a bench of Hon’ble Chief Justice Joymalya Bagchi and Hon’ble Justice V. Mohana.
  • Senior counsel for appellant: Mr. Gopal Sankarnarayanan, Sr. Adv.; Dr. Abhishek Manu Singhvi, Sr. Adv.; Dr. Rishab Gupta, Adv.; Mr. Rishabh Kapur, AOR. Respondent counsel: extensive senior counsel team led by Mr. Shyam Divan, Sr. Adv., Mr. Mukul Rohatgi, Sr. Adv., and many others.

Final Outcome

  • Court ordered the matters to be listed for further hearing on 11‑08‑2026.
  • The matters shall not be treated as part‑heard.

Topics: Court Proceedings, Foreign Investment Dispute